|
US1735350A
(en)
|
1921-07-02 |
1929-11-12 |
United Shoe Machinery Corp |
Machine for securing together two or more pieces of sheet material
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4318980A
(en)
|
1978-04-10 |
1982-03-09 |
Miles Laboratories, Inc. |
Heterogenous specific binding assay employing a cycling reactant as label
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5411947A
(en)
|
1989-06-28 |
1995-05-02 |
Vestar, Inc. |
Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
|
|
US5475120A
(en)
|
1990-11-02 |
1995-12-12 |
University Of Florida |
Method for the isolation and purification of taxol and its natural analogues
|
|
US5194635A
(en)
|
1991-03-18 |
1993-03-16 |
Virginia Tech Intellectual Properties, Inc. |
Rearranged taxol compounds and method of using in testing of in vivo activity
|
|
US5488116A
(en)
|
1992-03-30 |
1996-01-30 |
Sloan-Kettering Institute For Cancer Research |
Total synthesis of taxol and analogues thereof
|
|
US5416225A
(en)
|
1992-03-30 |
1995-05-16 |
Sloan-Kettering Institute For Cancer Research |
Total synthesis of taxol
|
|
US5440056A
(en)
|
1992-04-17 |
1995-08-08 |
Abbott Laboratories |
9-deoxotaxane compounds
|
|
CA2130578A1
(en)
|
1992-04-17 |
1993-10-28 |
Geewananda P. Gunawardana |
Taxol derivatives
|
|
US5461169A
(en)
|
1992-06-23 |
1995-10-24 |
The Scripps Research Institute |
Total synthesis of taxol and taxol analogs
|
|
US5440057A
(en)
|
1993-08-20 |
1995-08-08 |
The Scripps Research Institute |
Access to taxol analogs
|
|
WO1994005282A1
(en)
|
1992-09-04 |
1994-03-17 |
The Scripps Research Institute |
Water soluble taxol derivatives
|
|
US5478854A
(en)
|
1992-10-01 |
1995-12-26 |
Bristol-Myers Squibb Company |
Deoxy taxols
|
|
US5411984A
(en)
|
1992-10-16 |
1995-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Water soluble analogs and prodrugs of taxol
|
|
WO1994013827A1
(en)
|
1992-12-07 |
1994-06-23 |
Michigan State University |
PROCESS FOR THE ISOLATION AND PURIFICATION OF TAXOL AND TAXANES FROM TAXUS spp
|
|
US5468769A
(en)
|
1993-07-15 |
1995-11-21 |
Abbott Laboratories |
Paclitaxel derivatives
|
|
FR2707642B1
(fr)
|
1993-07-16 |
1995-10-13 |
Electricite De France |
Dérivés de polyéthers et d'hétérocycles pentacycliques, leurs polymères et leurs applications, notamment à la complexation d'ions métalliques.
|
|
US5405972A
(en)
|
1993-07-20 |
1995-04-11 |
Florida State University |
Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
|
|
US5565478A
(en)
|
1994-03-14 |
1996-10-15 |
The United States Of America As Represented By The Department Of Health & Human Services |
Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
|
|
US5508447A
(en)
|
1994-05-24 |
1996-04-16 |
Board Of Regents, The University Of Texas System |
Short synthetic route to taxol and taxol derivatives
|
|
US5489589A
(en)
|
1994-12-07 |
1996-02-06 |
Bristol-Myers Squibb Company |
Amino acid derivatives of paclitaxel
|
|
US7446181B2
(en)
|
1998-01-15 |
2008-11-04 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind human Dickkopf-1 proteins
|
|
WO2009028158A1
(en)
*
|
2007-08-24 |
2009-03-05 |
Oncotherapy Science, Inc. |
Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker
|
|
AR075989A1
(es)
|
2009-04-10 |
2011-05-11 |
Lilly Co Eli |
Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
|
|
CA3041325A1
(en)
*
|
2016-10-26 |
2018-05-03 |
Leap Therapeutics, Inc. |
Use of beta-catenin as a biomarker for treating cancers using anti-dkk-1 antibody
|
|
EP4061419A1
(en)
*
|
2019-11-22 |
2022-09-28 |
Leap Therapeutics, Inc. |
Methods of treating cancer using dkk-1-inhibitors
|